Epigenetic regulation of matrix metalloproteinase expression in ameloblastoma

BMC Clinical Pathology

Volumn 12, Issue , 2012, Pages

  Farias, Lucyana Conceição ^a   Gomes, Carolina Cavaliéri ^a   Rodrigues, Marcela Carolina ^a   De Castro, Wagner Henriques ^a   Lacerda, Júlio César Tanos ^b   E Ferreira, Efigênia Ferreira ^a   Gomez, Ricardo Santiago ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Department of Oral Surgery and Diagnosis   (Brazil)

Author keywords

Ameloblastoma; Epigenetic; Matrix metalloproteinases; Methylation; MMP 2; MMP 9; Odontogenic tumours

Indexed keywords

GELATINASE A; GELATINASE B; MESSENGER RNA;

ADOLESCENT; ADULT; AMELOBLASTOMA; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EPIGENETICS; FEMALE; GENE EXPRESSION; GINGIVA; HUMAN; MALE; METHYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; SCHOOL CHILD; ZYMOGRAPHY;

EID: 84870539533     PISSN: None     EISSN: 14726890     Source Type: Journal    
DOI: 10.1186/1472-6890-12-11     Document Type: Article

References (33)

1. Barnes L, Eveson JW, Reichart PA, Sidransky D, World Health Organization classification of tumors: pathology and genetics of tumours of the head and neck Lyon: IARC 2005 296 300
2. PTCH gene mutations in odontogenic keratocysts. Barreto DC, Gomez RS, Bale AE, Boson WL, De Marco L, J Dent Res 2000 79 1418 1422 10.1177/ 00220345000790061101 10890722 (Pubitemid 32489450)
3. Allelic loss of tumor suppressor genes in ameloblastic tumors. Nodit L, Barnes L, Childers E, Finkelstein S, Swalsky P, Hunt J, Mod Pathol 2004 17 1062 1067 10.1038/modpathol.3800147 15133474 (Pubitemid 39128232)
4. Molecular pathology of odontogenic tumors. Kumamoto H, J Oral Pathol Med 2006 35 65 74 10.1111/j.1600-0714.2006.00380.x 16430735
5. LINE-1 methylation difference between ameloblastoma and keratocystic odontogenic tumor. Kitkumthorn N, Mutirangura A, Oral Dis 2010 16 286 291 10.1111/j.1601-0825.2009.01640.x 20374511
6. Methylation of P16, P21, P27, RB1 and P53 genes in odontogenic keratocysts. Moreira PR, Guimarães MM, Guimarães AL, Diniz MG, Gomes CC, Brito JA, Gomez RS, J Oral Pathol Med 2009 38 99 103 19192054
7. Mechanisms of inactivation of PTCH1 gene in nevoid basal cell carcinoma syndrome: modification of the two-hit hypothesis. Pan S, Dong Q, Sun LS, Li TJ, Clin Cancer Res 2010 16 442 450 10.1158/1078-0432.CCR-09-2574 20068110
8. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Esteller M, Oncogene 2002 21 5427 5440 10.1038/sj.onc.1205600 12154405 (Pubitemid 34983479)
9. DNA methylation of human telomerase reverse transcriptase promoter region in human ameloblastoma. Zhong M, Yan Y, Wang J, Liu J, Li L, Gong YB, Zhonghua Kou Qiang Yi Xue Za Zhi 2007 42 304 307 17686286
10. Methylation frequencies of cell-cycle associated genes in epithelial odontogenic tumours. Moreira PR, Guimarães MM, Gomes CC, Diniz MG, Brito JA, de Castro WH, Gomez RS, Arch Oral Biol 2009 54 893 897 10.1016/j. archoralbio.2009.07.006 19679296
11. Regulation of matrix metalloproteinase activity in health and disease. Hadler-Olsen E, Fadnes B, Sylte I, Uhlin-Hansen L, Winberg JO, FEBS J 2011 278 28 45 10.1111/j.1742-4658.2010.07920.x 21087458
12. Ameloblastoma induces osteoclastogenesis: a possible role of ameloblastoma in expanding in the bone. Sandra F, Hendarmin L, Kukita T, Nakao Y, Nakamura N, Nakamura S, Oral Oncol 2005 41 637 644 10.1016/j.oraloncology. 2005.02.008 15935726 (Pubitemid 40828882)
13. Expression of bone morphogenetic proteins and their associated molecules in ameloblastomas and adenomatoid odontogenic tumors. Kumamoto H, Ooya K, Oral Dis 2006 12 163 170 10.1111/j.1601-0825.2005.01177.x 16476038
14. Suppression of local invasion of ameloblastoma by inhibition of matrix metalloproteinase-2 in vitro. Wang A, Zhang B, Huang H, Zhang L, Zeng D, Tao Q, Wang J, Pan C, BMC Cancer 2008 8 182 10.1186/1471-2407-8-182 18588710 (Pubitemid 352003726)
15. Inhibition of ameloblastoma invasion in vitro and in vivo by inhibitor of metalloproteinase-2 activity. Zhang B, Zhang J, Huang HZ, Chen WL, Tao Q, Zeng DL, Zhang LT, Xu JH, J Oral Pathol Med 2009 38 731 736 10.1111/j.1600-0714.2009. 00771.x 19473446
16. Expression and role of metalloproteinase-2 and endogenous tissue regulator in ameloblastoma. Zhang B, Zhang J, Huang HZ, Xu ZY, Xie HL, J Oral Pathol Med 2010 39 219 222 10.1111/j.1600-0714.2009.00827.x 19709349
17. The role of RANKL and MMP-9 in the bone resorption caused by ameloblastoma. Qian Y, Huang HZ, J Oral Pathol Med 2010 39 592 598 10.1111/j.1600-0714.2009.00882.x 20412401
18. Alteration of the methylation status of tumor-promoting genes decreases prostate cancer cell invasiveness and tumorigenesis in vitro and in vivo. Shukeir N, Pakneshan P, Chen G, Szyf M, Rabbani SA, Cancer Res 2006 66 9202 9210 10.1158/0008-5472.CAN-06-1954 16982764 (Pubitemid 44521141)
19. Epigenetic control of the invasion-promoting MT1-MMP/MMP-2/TIMP-2 axis in cancer cells. Chernov AV, Sounni NE, Remacle AG, Strongin AY, J Biol Chem 2009 284 12727 12734 10.1074/jbc.M900273200 19286653
20. MethPrimer: designing primers for methylation PCRs. Li LC, Dahiya R, Bioinformatics 2002 18 1427 1431 10.1093/bioinformatics/18.11.1427 12424112 (Pubitemid 35414532)
21. Association between the abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regions. Roach HI, Yamada N, Cheung KS, Tilley S, Clarke NM, Oreffo RO, Kokubun S, Bronner F, Arthritis Rheum 2005 52 3110 3124 10.1002/art.21300 16200590 (Pubitemid 41447092)
22. Analysis of relative gene expression data using real-time quantitative PCR and the 2-CT method. Livak KJ, Schmittgen TD, Methods 2001 25 402 408 10.1006/meth.2001.1262 11846609 (Pubitemid 34164012)
23. Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors. Snoek-van Beurden PA, Von den Hoff JW, Biotechniques 2005 38 73 83 10.2144/05381RV01 15679089 (Pubitemid 40139420)
24. Current concepts of ameloblastoma pathogenesis. Gomes CC, Duarte AP, Diniz MG, Gomez R, J Oral Pathol Med 2010 39 585 591 10.1111/j.1600-0714.2010. 00908.x 20618608
25. Loss of heterozygosity of the PTCH gene in ameloblastoma. Farias LC, Gomes CC, Brito JA, Galvão CF, Diniz MG, de Castro WH, Bernardes VD, De Marco LA, Gomez RS, Hum Pathol 2012 43 1229 1233 10.1016/j.humpath.2011.08.026 22221699
26. Immunohistochemical detection of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in ameloblastomas. Kumamoto H, Yamauchi K, Yoshida M, Ooya K, J Oral Pathol Med 2003 32 114 120 10.1034/j.1600-0714.2003.00086.x 12542835 (Pubitemid 36604038)
27. Immunoexpression of matrix metalloproteinase-2 and matrix metalloproteinase-9 in the metastasis of squamous cell carcinoma of the human tongue. Zhou CX, Gao Y, Johnson NW, Gao J, Aust Dent J 2010 55 385 389 10.1111/j.1834-7819.2010.01258.x 21174909
28. Hypomethylation of tumor suppressor genes in odontogenic myxoma. Moreira PR, Cardoso FP, Brito JA, Batista AC, Gomes CC, Gomez RS, Braz Dent J 2011 22 422 427 10.1590/S0103-64402011000500013 22011900
29. MT1-MMP expression in the odontogenic region of rat incisors undergoing interrupted eruption. Omar NF, Gomes JR, Neves JD, Salmon CR, Novaes PD, J Mol Histol 2011 42 505 511 10.1007/s10735-011-9356-0 21909755
30. Structure of the human type IV collagenase gene. Huhtala P, Chow LT, Tryggvason K, J Biol Chem 1990 265 11077 11082 2162831
31. Localization of matrix metalloproteinase-2 within the aneurysmal and normal aortic wall. Crowther M, Goodall S, Jones JL, Bell PR, Thompson MM, Br J Surg 2000 87 1391 1400 10.1046/j.1365-2168.2000.01554.x 11044166
32. Ubiquitous elevation of matrix metalloproteinase-2 expression in the vasculature of patients with abdominal aneurysms. Goodall S, Crowther M, Hemingway DM, Bell PR, Thompson MM, Circulation 2001 104 304 309 10.1161/01.CIR.104.3.304 11457749 (Pubitemid 32666952)
33. Evidence for the role of promoter methylation in the regulation of MMP-9 gene expression. Chicoine E, Estève PO, Robledo O, Van Themsche C, Potworowski EF, St-Pierre Y, Biochem Biophys Res Commun 2002 297 765 772 10.1016/S0006-291X(02)02283-0 12359218 (Pubitemid 35230316)